Search for a report

GLOBAL STEM CELL MARKET FORECAST 2021-2028

  • You are here:
  • Home
  • Downloads
  • GLOBAL STEM CELL MARKET FORECAST 2021-2028

GLOBAL STEM CELL MARKET FORECAST 2021-2028

The global stem cell market is projected to register a CAGR of 7.82% during the forecast period, and is anticipated to generate revenue of $17301.7 million by 2028. The base year considered for the market study is 2020, and the forecast years are from 2021 to 2028. Stem cells possess the potential to develop into different types of cells within the body, and are also used to make tissues and cells for treating several diseases.

GLOBAL STEM CELL MARKET FORECAST 2021-2028

Global Stem Cell Market by Therapeutic Application (Orthopedic Treatments, Injuries and Wounds, Oncology Disorders, Cardiovascular Disorders, Neurological Disorders, Diabetes, Other Therapeutic Applications) by Product (Adult Stem Cell (Hematopoietic Stem Cell, Neural Stem, Umbilical Cord Stem Cell, Mesenchymal Stem Cell, Dental Stem Cell), Human Embryonic Stem Cell, Pluripotent, Mouse/rat Neural) by Technology (Acquisition (Stem Cell Bone Marrow Market, Stem Cell Apheresis, Stem Cell Umbilical Cord), Cryopreservation, Expansion and Sub-culture, Production (Stem Cell Culture, Therapeutic Cloning, Ivf)) by Application (Regenerative Medicine, Drug Discovery and Development) by Treatment Type (Allogeneic Stem Cell Therapy, Autologic Stem Cell Therapy, Syngeneic Stem Cell Therapy) and by Geography.

Request free sample

The global stem cell market is projected to register a CAGR of 7.82% during the forecast period, and is anticipated to generate revenue of $17301.7 million by 2028. The base year considered for the market study is 2020, and the forecast years are from 2021 to 2028.

Stem cells possess the potential to develop into different types of cells within the body, and are also used to make tissues and cells for treating several diseases. These include Alzheimer’s disease, Parkinson’s disease, spinal cord injury, diabetes, heart diseases, and arthritis.
global-states-stem-cell-market

To learn more about this report, request a free sample copy

Key factors propelling the global stem cell market growth:

  • Surging demand for stem cells in regenerative medicine
  • Growing R&D investments in stem cell therapies and research
    • The rising number of government initiatives and clinical trials associated with stem cell research promotes the global stem cell market growth.
    • For instance, the California Stem Cell Research, Treatments, and Cures Initiative of 2020, received its government approval in 2019.
  • Rising awareness about umbilical cord stem cells
  • Reduced risk of tissue rejection in transplants
  • Technological advancements

Major restraining factors limiting the global stem cell market growth:

  • Stringent government regulations
  • High cost associated with stem cell procedures
  • Ethical issues and social complexities associated with stem cells
    • Generating stem cells from the human embryo or adult stem cells for the purpose of research, saving, maintenance, and using embryos, is among the main legal and ethical concerns observed in emerging countries.
    • As a result, this is likely to restrain the market growth during the forecast period.
  • Less responsiveness in the developed economies

The report scope of the global stem cell market includes the segmentation analysis of therapeutic application, product, technology, application, and treatment type. One of these segments is further classified to provide a detailed analysis of the studied market.

Market by Therapeutic Application:

  • Orthopedic Treatments
    • The orthopedic treatments segment is expected to dominate the therapeutic application category.
    • Orthopedic treatments speed up the recovery time for various injuries and are fairly less invasive than other surgical procedures.
    • As a result, stem cell therapies have gained added popularity among athletes, particularly for healing potentially career-ending injuries.
  • Oncology Disorders
    • Oncology disorders is the fastest-growing therapeutic application.
    • Bone marrow transplant or stem cell transplant helps treat different kinds of cancer, such as leukemia, multiple myeloma, neuroblastoma, and certain lymphoma types.
    • Moreover, both autologous and allogeneic stem cell transplants are conducted for cancer treatments.
  • Injuries and Wounds
  • Diabetes
  • Cardiovascular Disorders
  • Neurological disorders
  • Other Therapeutic Applications

Geographically, the global stem cell market has been segmented based on four major regions, which includes:

  • North America: The United States and Canada
    • North America is set to dominate the global stem cell market over the forecast period.
    • The increasing number of cancer cases provides numerous opportunities for market players.
    • Besides, key industries primarily focus on R&D activities, in order to introduce new stem cell therapies in the market.
    • The National Cancer Institute (NCI) stated that the national cancer care expenditure is expected to reach $156 billion, by 2020, thereby facilitating market growth.
  • Europe: The United Kingdom, Germany, Italy, France, Belgium, Russia, Poland, and Rest of Europe
  • Asia Pacific: India, Australia & New Zealand, China, South Korea, Japan, Thailand, Indonesia, Vietnam, and Rest of Asia Pacific
    • The Asia Pacific is expected to lead the global stem cell market, during the forecast years.
    • The rising focus on clinical research, regenerative medicines, technological developments, and the growing number of chronic conditions essentially drive the growth of the market studied.
    • Since therapies are gaining positive results, in terms of treating incurable diseases, companies across the region are gaining lucrative opportunities to work on stem cells.
  • Rest of World: Latin America, the Middle East & Africa

The major market players operating in the global stem cell market: 

  • Becton, Dickinson, and Company (BD)
  • Corning Inc
  • GE healthcare
  • Qiagen NV
  • Smith & Nephew PLC
  • Others

Key strategies adopted by some of these companies:

In March 2020, Thermo Fisher Scientific signed an agreement with Janssen Biotech Inc, to co-develop a companion diagnostic in oncology. Also, in October 2020, Merck publicized that the company has signed contracts licensing its CRISPR technology to two organizations, Takara Bio USA, Inc, and PanCELLa.

Key findings of the global stem cell market:

  • Stem cells serve as an emerging application, in terms of being a drug discovery tool.
  • Stem cell technology plays a crucial role in anti-aging and prolonging life.
  • Oncology disorders is the fastest-growing therapeutic application.
  • The adult stem cell segment dominates the product category.

 

Frequently Asked Questions & Answers (FAQs):

  • What is the impact of pluripotent stem cells on the global stem cell market?

A: Multiple experiments conducted within pluripotent stem cells are expected to augment the market growth. For instance, in September 2018, researchers from the United States and China developed a novel bio-ink capable of efficiently bioprinting and expanding the human-induced pluripotent stem cells.

  • How are stem cells beneficial for patients infected by COVID-19?

A: According to a present study, a severely ill patient infected with the novel Coronavirus remarkably recovered after being treated with umbilical cord stem cell therapy. Besides, various other clinical trials are also focusing on umbilical cord stem cells to treat COVID-19.

  • What could be an effective and strategic initiative for the global stem cell market growth?

A: The collaboration between Big Data companies and stem cell companies has enhanced the potential of understanding diseases at a relatively greater level. Moreover, biorepositories currently have clinicians and researchers examining high-quality biological samples, to study diseases and treatments.

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    •    KEY DRIVERS
      • SURGING DEMAND OF STEM CELLS IN REGENERATIVE MEDICINE
      • GROWING R&D INVESTMENTS IN STEM CELL THERAPIES AND RESEARCH
      • RISING AWARENESS ABOUT UMBILICAL CORD STEM CELLS
      • REDUCED RISK OF TISSUE REJECTION IN TRANSPLANTS
      • TECHNOLOGICAL ADVANCEMENTS
    •    KEY RESTRAINTS
      • STRINGENT GOVERNMENT REGULATIONS
      • HIGH COST ASSOCIATED WITH STEM CELL PROCEDURES
      • ETHICAL ISSUES AND SOCIAL COMPLEXITIES ASSOCIATED WITH STEM CELLS
      • LESS RESPONSIVENESS IN DEVELOPED ECONOMIES
  1. KEY ANALYTICS
    •    PORTER’S FIVE FORCES ANALYSIS
      • THREAT OF NEW ENTRY
      • THREAT OF SUBSTITUTION
      • BUYER’S POWER
      • SUPPLIER’S POWER
      • COMPETITIVE RIVALRY
    • IMPACT OF COVID-19 ON STEM CELL MARKET
    • VALUE CHAIN ANALYSIS
    • KEY BUYING CRITERIA
    • HISTORY OF STEM CELL
    • REGULATORY FRAMEWORK
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • KEY INVESTMENT INSIGHTS
  2. MARKET BY THERAPEUTIC APPLICATION
    • ORTHOPEDIC TREATMENTS
    • INJURIES AND WOUNDS
    • ONCOLOGY DISORDERS
    • CARDIOVASCULAR DISORDERS
    • NEUROLOGICAL DISORDERS
    • DIABETES
    • OTHER THERAPEUTIC APPLICATIONS
  3. MARKET BY PRODUCT
    •    ADULT STEM CELL
      • HEMATOPOIETIC STEM CELL
      • NEURAL STEM
      • UMBILICAL CORD STEM CELL
      • MESENCHYMAL STEM CELL
      • DENTAL STEM CELL
    • HUMAN EMBRYONIC STEM CELL
    • PLURIPOTENT
    • MOUSE/RAT NEURAL
  4. MARKET BY TECHNOLOGY
    •    ACQUISITION
      • STEM CELL BONE MARROW MARKET
      • STEM CELL APHERESIS
      • STEM CELL UMBILICAL CORD
    • CRYOPRESERVATION
    • EXPANSION AND SUB-CULTURE
    •    PRODUCTION
      • STEM CELL CULTURE
      • THERAPEUTIC CLONING
      • IVF
  1. MARKET BY APPLICATION
    • REGENERATIVE MEDICINE
    • DRUG DISCOVERY AND DEVELOPMENT
  2. MARKET BY TREATMENT TYPE
    • ALLOGENEIC STEM CELL THERAPY
    • AUTOLOGIC STEM CELL THERAPY
    • SYNGENEIC STEM CELL THERAPY
  3. GEOGRAPHICAL ANALYSIS
    •    NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      •    COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    •     EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      •    COUNTRY ANALYSIS
        • GERMANY
        • FRANCE
        • UNITED KINGDOM
        • ITALY
        • RUSSIA
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    •     ASIA PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      •    COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • AUSTRALIA & NEW ZEALAND
        • SOUTH KOREA
        • THAILAND
        • INDONESIA
        • VIETNAM
        • REST OF ASIA PACIFIC
    •     REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      •    REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA
  1. COMPETITIVE LANDSCAPE
    •    KEY STRATEGIC DEVELOPMENTS
      • MERGER & ACQUISITIONS
      • PRODUCT LAUNCH & DEVELOPMENTS
      • PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
      • BUSINESS EXPANSION/ APPROVAL/ ANNOUNCEMENT
    •    COMPANY PROFILE
      • ALLCELLS LLC
      • BECTON, DICKINSON AND COMPANY (BD)
      • CORNING INC
      • CYTORI THERAPEUTICS
      • GE HEALTHCARE
      • INTERNATIONAL STEM CELL CORP
      • MERCK KGAA (SIGMA ALDRICH)
      • MILTENYI BIOTEC
      • PLURISTEM THERAPEUTICS INC
      • QIAGEN NV
      • SMITH & NEPHEW PLC
      • STEMCELL TECHNOLOGIES
      • STRYKER CORPORATION
      • TAKARA HOLDINGS INC
      • THERMO FISHER SCIENTIFIC INC

TABLE LIST

TABLE 1: MARKET SNAPSHOT – STEM CELL

TABLE 2: GLOBAL STEM CELL MARKET, BY THERAPEUTIC APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 3: GLOBAL STEM CELL MARKET, BY THERAPEUTIC APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 4: GLOBAL ORTHOPEDIC TREATMENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 5: GLOBAL ORTHOPEDIC TREATMENTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 6: GLOBAL INJURIES AND WOUNDS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: GLOBAL INJURIES AND WOUNDS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 8: GLOBAL ONCOLOGY DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 9: GLOBAL ONCOLOGY DISORDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 10: GLOBAL CARDIOVASCULAR DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 11: GLOBAL CARDIOVASCULAR DISORDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 12: GLOBAL NEUROLOGICAL DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 13: GLOBAL NEUROLOGICAL DISORDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 14: GLOBAL DIABETES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 15: GLOBAL DIABETES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 16: GLOBAL OTHER THERAPEUTIC APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 17: GLOBAL OTHER THERAPEUTIC APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 18: GLOBAL STEM CELL MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 19: GLOBAL STEM CELL MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 20: GLOBAL ADULT STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 21: GLOBAL ADULT STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 22: GLOBAL ADULT STEM CELL MARKET, BY TYPES, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 23: GLOBAL ADULT STEM CELL MARKET, BY TYPES, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 24: GLOBAL HEMATOPOIETIC STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 25: GLOBAL HEMATOPOIETIC STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 26: GLOBAL NEURAL STEM MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 27: GLOBAL NEURAL STEM MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 28: GLOBAL UMBILICAL CORD STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 29: GLOBAL UMBILICAL CORD STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 30: GLOBAL MESENCHYMAL STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 31: GLOBAL MESENCHYMAL STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 32: GLOBAL DENTAL STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 33: GLOBAL DENTAL STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 34: GLOBAL HUMAN EMBRYONIC STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 35: GLOBAL HUMAN EMBRYONIC STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 36: GLOBAL PLURIPOTENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 37: GLOBAL PLURIPOTENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 38: GLOBAL MOUSE/RAT NEURAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 39: GLOBAL MOUSE/RAT NEURAL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 40: GLOBAL STEM CELL MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 41: GLOBAL STEM CELL MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 42: GLOBAL ACQUISITION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 43: GLOBAL ACQUISITION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 44: GLOBAL ACQUISITION MARKET, BY TYPES, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 45: GLOBAL ACQUISITION MARKET, BY TYPES, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 46: GLOBAL STEM CELL BONE MARROW MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 47: GLOBAL STEM CELL BONE MARROW MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 48: GLOBAL STEM CELL APHERESIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 49: GLOBAL STEM CELL APHERESIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 50: GLOBAL STEM CELL UMBILICAL CORD MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 51: GLOBAL STEM CELL UMBILICAL CORD MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 52: GLOBAL CRYOPRESERVATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 53: GLOBAL CRYOPRESERVATION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 54: GLOBAL EXPANSION AND SUB-CULTURE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 55: GLOBAL EXPANSION AND SUB-CULTURE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 56: GLOBAL PRODUCTION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 57: GLOBAL PRODUCTION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 58: GLOBAL PRODUCTION MARKET, BY TYPES, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 59: GLOBAL PRODUCTION MARKET, BY TYPES, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 60: GLOBAL STEM CELL CULTURE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 61: GLOBAL STEM CELL CULTURE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 62: GLOBAL THERAPEUTIC CLONING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 63: GLOBAL THERAPEUTIC CLONING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 64: GLOBAL IVF MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 65: GLOBAL IVF MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 66: GLOBAL STEM CELL MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 67: GLOBAL STEM CELL MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 68: GLOBAL REGENERATIVE MEDICINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 69: GLOBAL REGENERATIVE MEDICINE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 70: GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 71: GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 72: GLOBAL STEM CELL MARKET, BY TREATMENT TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 73: GLOBAL STEM CELL MARKET, BY TREATMENT TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 74: GLOBAL ALLOGENEIC STEM CELL THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 75: GLOBAL ALLOGENEIC STEM CELL THERAPY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 76: GLOBAL AUTOLOGIC STEM CELL THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 77: GLOBAL AUTOLOGIC STEM CELL THERAPY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 78: GLOBAL SYNGENEIC STEM CELL THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 79: GLOBAL SYNGENEIC STEM CELL THERAPY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 80: GLOBAL STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 81: GLOBAL STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 82: NORTH AMERICA STEM CELL MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 83: NORTH AMERICA STEM CELL MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 84: LEADING PLAYERS OPERATING IN NORTH AMERICA STEM CELL MARKET

TABLE 85: EUROPE STEM CELL MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 86: EUROPE STEM CELL MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 87: LEADING PLAYERS OPERATING IN EUROPE STEM CELL MARKET

TABLE 88: ASIA PACIFIC STEM CELL MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 89: ASIA PACIFIC STEM CELL MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 90: LEADING PLAYERS OPERATING IN ASIA PACIFIC STEM CELL MARKET

TABLE 91: REST OF WORLD STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 92: REST OF WORLD STEM CELL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 93: LEADING PLAYERS OPERATING IN REST OF WORLD STEM CELL MARKET

FIGURES LIST

FIGURE 1: PORTER’S FIVE FORCE ANALYSIS

FIGURE 2: OPPORTUNITY MATRIX

FIGURE 3: VENDOR LANDSCAPE

FIGURE 4: KEY INVESTMENT INSIGHTS

FIGURE 5: GLOBAL STEM CELL MARKET, BY THERAPEUTIC APPLICATION, IN 2020

FIGURE 6: GLOBAL STEM CELL MARKET, BY ORTHOPEDIC TREATMENTS, 2021-2028 (IN $ MILLION)

FIGURE 7: GLOBAL STEM CELL MARKET, BY INJURIES AND WOUNDS, 2021-2028 (IN $ MILLION)

FIGURE 8: GLOBAL STEM CELL MARKET, BY ONCOLOGY DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 9: GLOBAL STEM CELL MARKET, BY CARDIOVASCULAR DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 10: GLOBAL STEM CELL MARKET, BY NEUROLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 11: GLOBAL STEM CELL MARKET, BY DIABETES, 2021-2028 (IN $ MILLION)

FIGURE 12: GLOBAL STEM CELL MARKET, BY OTHER THERAPEUTIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 13: GLOBAL STEM CELL MARKET, BY PRODUCT, IN 2020

FIGURE 14: GLOBAL STEM CELL MARKET, BY ADULT STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 15: GLOBAL STEM CELL MARKET, BY HEMATOPOIETIC STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 16: GLOBAL STEM CELL MARKET, BY NEURAL STEM, 2021-2028 (IN $ MILLION)

FIGURE 17: GLOBAL STEM CELL MARKET, BY UMBILICAL CORD STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 18: GLOBAL STEM CELL MARKET, BY MESENCHYMAL STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 19: GLOBAL STEM CELL MARKET, BY DENTAL STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 20: GLOBAL STEM CELL MARKET, BY HUMAN EMBRYONIC STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 21: GLOBAL STEM CELL MARKET, BY PLURIPOTENT, 2021-2028 (IN $ MILLION)

FIGURE 22: GLOBAL STEM CELL MARKET, BY MOUSE/RAT NEURAL, 2021-2028 (IN $ MILLION)

FIGURE 23: GLOBAL STEM CELL MARKET, BY TECHNOLOGY, IN 2020

FIGURE 24: GLOBAL STEM CELL MARKET, BY ACQUISITION, 2021-2028 (IN $ MILLION)

FIGURE 25: GLOBAL STEM CELL MARKET, BY STEM CELL BONE MARROW MARKET, 2021-2028 (IN $ MILLION)

FIGURE 26: GLOBAL STEM CELL MARKET, BY STEM CELL APHERESIS, 2021-2028 (IN $ MILLION)

FIGURE 27: GLOBAL STEM CELL MARKET, BY STEM CELL UMBILICAL CORD, 2021-2028 (IN $ MILLION)

FIGURE 28: GLOBAL STEM CELL MARKET, BY CRYOPRESERVATION, 2021-2028 (IN $ MILLION)

FIGURE 29: GLOBAL STEM CELL MARKET, BY EXPANSION AND SUB-CULTURE, 2021-2028 (IN $ MILLION)

FIGURE 30: GLOBAL STEM CELL MARKET, BY PRODUCTION, 2021-2028 (IN $ MILLION)

FIGURE 31: GLOBAL STEM CELL MARKET, BY STEM CELL CULTURE, 2021-2028 (IN $ MILLION)

FIGURE 32: GLOBAL STEM CELL MARKET, BY THERAPEUTIC CLONING, 2021-2028 (IN $ MILLION)

FIGURE 33: GLOBAL STEM CELL MARKET, BY IVF, 2021-2028 (IN $ MILLION)

FIGURE 34: GLOBAL STEM CELL MARKET, BY APPLICATION, IN 2020

FIGURE 35: GLOBAL STEM CELL MARKET, BY REGENERATIVE MEDICINE, 2021-2028 (IN $ MILLION)

FIGURE 36: GLOBAL STEM CELL MARKET, BY DRUG DISCOVERY AND DEVELOPMENT, 2021-2028 (IN $ MILLION)

FIGURE 37: GLOBAL STEM CELL MARKET, BY TREATMENT TYPE, IN 2020

FIGURE 38: GLOBAL STEM CELL MARKET, BY ALLOGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 39: GLOBAL STEM CELL MARKET, BY AUTOLOGIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 40: GLOBAL STEM CELL MARKET, BY SYNGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 41: NORTH AMERICA STEM CELL MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 42: UNITED STATES STEM CELL MARKET, 2021-2028 (IN $ MILLION)

FIGURE 43: CANADA STEM CELL MARKET, 2021-2028 (IN $ MILLION)

FIGURE 44: EUROPE STEM CELL MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 45: GERMANY STEM CELL MARKET, 2021-2028 (IN $ MILLION)

FIGURE 46: FRANCE STEM CELL MARKET, 2021-2028 (IN $ MILLION)

FIGURE 47: UNITED KINGDOM STEM CELL MARKET, 2021-2028 (IN $ MILLION)

FIGURE 48: ITALY STEM CELL MARKET, 2021-2028 (IN $ MILLION)

FIGURE 49: RUSSIA STEM CELL MARKET, 2021-2028 (IN $ MILLION)

FIGURE 50: BELGIUM STEM CELL MARKET, 2021-2028 (IN $ MILLION)

FIGURE 51: POLAND STEM CELL MARKET, 2021-2028 (IN $ MILLION)

FIGURE 52: REST OF EUROPE STEM CELL MARKET, 2021-2028 (IN $ MILLION)

FIGURE 53: ASIA PACIFIC STEM CELL MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 54: CHINA STEM CELL MARKET, 2021-2028 (IN $ MILLION)

FIGURE 55: JAPAN STEM CELL MARKET, 2021-2028 (IN $ MILLION)

FIGURE 56: INDIA STEM CELL MARKET, 2021-2028 (IN $ MILLION)

FIGURE 57: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, 2021-2028 (IN $ MILLION)

FIGURE 58: SOUTH KOREA STEM CELL MARKET, 2021-2028 (IN $ MILLION)

FIGURE 59: THAILAND STEM CELL MARKET, 2021-2028 (IN $ MILLION)

FIGURE 60: INDONESIA STEM CELL MARKET, 2021-2028 (IN $ MILLION)

FIGURE 61: VIETNAM STEM CELL MARKET, 2021-2028 (IN $ MILLION)

FIGURE 62: REST OF ASIA PACIFIC STEM CELL MARKET, 2021-2028 (IN $ MILLION)

FIGURE 63: REST OF WORLD STEM CELL MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 64: LATIN AMERICA STEM CELL MARKET, 2021-2028 (IN $ MILLION)

FIGURE 65: MIDDLE EAST & AFRICA STEM CELL MARKET, 2021-2028 (IN $ MILLION)

  1. MARKET BY THERAPEUTIC APPLICATION
    • ORTHOPEDIC TREATMENTS
    • INJURIES AND WOUNDS
    • ONCOLOGY DISORDERS
    • CARDIOVASCULAR DISORDERS
    • NEUROLOGICAL DISORDERS
    • DIABETES
    • OTHER THERAPEUTIC APPLICATIONS
  2. MARKET BY PRODUCT
    •    ADULT STEM CELL
      • HEMATOPOIETIC STEM CELL
      • NEURAL STEM
      • UMBILICAL CORD STEM CELL
      • MESENCHYMAL STEM CELL
      • DENTAL STEM CELL
    • HUMAN EMBRYONIC STEM CELL
    • PLURIPOTENT
    • MOUSE/RAT NEURAL
  3. MARKET BY TECHNOLOGY
    •    ACQUISITION
      • STEM CELL BONE MARROW MARKET
      • STEM CELL APHERESIS
      • STEM CELL UMBILICAL CORD
    • CRYOPRESERVATION
    • EXPANSION AND SUB-CULTURE
    •    PRODUCTION
      • STEM CELL CULTURE
      • THERAPEUTIC CLONING
      • IVF
  1. MARKET BY APPLICATION
    • REGENERATIVE MEDICINE
    • DRUG DISCOVERY AND DEVELOPMENT
  2. MARKET BY TREATMENT TYPE
    • ALLOGENEIC STEM CELL THERAPY
    • AUTOLOGIC STEM CELL THERAPY
    • SYNGENEIC STEM CELL THERAPY
  3. GEOGRAPHICAL ANALYSIS
    •    NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      •    COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    •    EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      •    COUNTRY ANALYSIS
        • GERMANY
        • FRANCE
        • UNITED KINGDOM
        • ITALY
        • RUSSIA
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    •     ASIA PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      •    COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • AUSTRALIA & NEW ZEALAND
        • SOUTH KOREA
        • THAILAND
        • INDONESIA
        • VIETNAM
        • REST OF ASIA PACIFIC
    •     REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      •    REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    Choose License Type

    Buy Now